Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: A potential role for dysregulation of the transforming growth factor-β pathway-Reference-Cited by-同舟云学术

Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: A potential role for dysregulation of the transforming growth factor-β pathway

Published:2007-02 Issue:3 Volume:43 Page:624-631
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Baker Kristi,Zlobec Inti,Tornillo Luigi,Terracciano Luigi,Jass Jeremy R.,Lugli Alessandro

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Emerging concepts in colorectal neoplasia;Jass;Gastroenterology,2002

2. Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis;Guidoboni;Am J Pathol,2001

3. CD103+ intraepithelial lymphocytes – a unique population in microsatellite unstable sporadic colorectal cancer;Quinn;Eur J Cancer,2003

4. Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease;Di Sabatino;Gut,2001

5. Lymphokine-activated killing by human intestinal lymphocytes;Ebert;Cell Immunol,1993

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The next bastion to be conquered in immunotherapy: microsatellite stable colorectal cancer;Frontiers in Immunology;2023-12-22

2. Tumor stroma Siglec15 expression is a poor prognosis predictor in colon adenocarcinoma;Journal of Cancer;2023

3. Assessment of the RANTES Level Correlation and Selected Inflammatory and Pro-Angiogenic Molecules Evaluation of Their Influence on CRC Clinical Features: A Preliminary Observational Study;Medicina;2022-01-28

4. Clinical Application of Adaptive Immune Therapy in MSS Colorectal Cancer Patients;Frontiers in Immunology;2021-10-13

5. Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN–driven CCL5 and CXCL10;Journal of Experimental Medicine;2021-07-23